HuGE Literature Finder
Records 1-5
The value of blood cytokines and chemokines in assessing COPD.
Respiratory research 2017 Oct 18 (1): 180. Bradford Eric, Jacobson Sean, Varasteh Jason, Comellas Alejandro P, Woodruff Prescott, O'Neal Wanda, DeMeo Dawn L, Li Xingnan, Kim Victor, Cho Michael, Castaldi Peter J, Hersh Craig, Silverman Edwin K, Crapo James D, Kechris Katerina, Bowler Russell |
Influence of SIGLEC9 polymorphisms on COPD phenotypes including exacerbation frequency.
Respirology (Carlton, Vic.) 2016 Nov . Ishii Takeo, Angata Takashi, Wan Emily S, Cho Michael H, Motegi Takashi, Gao Congxiao, Ohtsubo Kazuaki, Kitazume Shinobu, Gemma Akihiko, ParÉ Peter D, Lomas David A, Silverman Edwin K, Taniguchi Naoyuki, Kida Koz |
Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema.
The European respiratory journal 2003 Mar 21 (3): 444-9. Ferrarotti I, Zorzetto M, Beccaria M, Gilè L S, Porta R, Ambrosino N, Pignatti P F, Cerveri I, Pozzi E, Luisetti |
Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD.
Chest 2002 Aug 122 (2): 416-20. Sakao Seiichiro, Tatsumi Koichiro, Igari Hidetoshi, Watanabe Reiko, Shino Yuji, Shirasawa Hiroshi, Kuriyama Takayu |
Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease.
Respiratory research 2002 3 (): 29. Küçükaycan Mehmet, Van Krugten Michiel, Pennings Herman-Jan, Huizinga Tom W J, Buurman Wim A, Dentener Mieke A, Wouters Emiel F |
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 15, 2021
- Content source: